Ascendis Pharma A/S

(NASDAQ:ASND)

Latest On Ascendis Pharma A/S (ASND):

Date/Time Type Description Signal Details
2023-05-08 18:47 ESTNewsAscendis Pharma added to Wedbush's best ideas listN/A
2023-05-02 17:38 ESTNewsAscendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To ClearN/A
2023-05-01 17:06 ESTNewsAscendis' TransCon gets FDA rejection but company hopeful as no new trials requestedN/A
2023-04-28 02:05 ESTNewsAscendis Pharma A/S (ASND) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 01:02 ESTNewsAscendis Pharma Q1 2023 Earnings PreviewN/A
2023-04-20 16:46 ESTNewsAscendis Pharma: A Promising Diversification PlayN/A
2023-04-17 01:29 ESTNewsAscendis Pharma: Recent FDA Setbacks Present A Buying OpportunityN/A
2023-04-06 23:12 ESTNewsAscendis Pharma: Is Dip On TransCon Application A Buy Opportunity?N/A
2023-04-03 14:24 ESTNewsAscendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon applicationN/A
2023-04-03 14:24 ESTNewsAscendis downgraded at Credit Suisse on deficiencies in drug applicationN/A
2023-02-17 11:10 ESTNewsAscendis Pharma A/S (ASND) Q4 2022 Earnings Call TranscriptN/A
2023-02-16 22:05 ESTNewsAscendis Pharma GAAP EPS of -€10.40, revenue of €51.17MN/A
2023-02-15 19:21 ESTNewsAscendis Pharma FY 2022 Earnings PreviewN/A
2023-01-27 16:41 ESTNewsAscendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral RatingN/A
2023-01-19 02:12 ESTNewsAscendis Pharma: Group's Best Nearby Capital Gain Price-Position StockN/A
2022-11-17 14:37 ESTNewsAscendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trialN/A
2022-11-14 19:34 ESTNewsAscendis falls on Phase 2 data for achondroplasia candidateN/A
2022-11-05 05:43 ESTNewsAscendis Pharma A/S (ASND) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 12:46 ESTNewsAscendis Pharma: Translating Valuable IP Into A Profitable BusinessN/A
2022-11-03 02:59 ESTNewsAscendis Pharma GAAP EPS of -€3.03, revenue of €15.29MN/A
2022-11-01 19:43 ESTNewsAscendis Pharma Q3 2022 Earnings PreviewN/A
2022-11-01 03:36 ESTNewsAscendis parathyroid hormone therapy goes under FDA priority reviewN/A
2022-09-16 02:59 ESTNewsAscendis Pharma: TransCon CNP Data Coming Q4N/A
2022-08-31 23:18 ESTNewsAscendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTHN/A
2022-08-11 20:08 ESTNewsAscendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug SkytrofaN/A
2022-08-11 03:38 ESTNewsAscendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15BN/A
2022-08-11 03:37 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 09:43 ESTNewsAscendis Pharma Q2 2022 Earnings PreviewN/A
2022-08-04 05:34 ESTNewsAscendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain ProspectN/A
2022-05-23 09:02 ESTNewsAscendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in childrenN/A
2022-05-13 04:45 ESTNewsAscendis Pharma slides after Street analysts cut price target over SKYTROFA revenue missN/A
2022-05-12 09:00 ESTNewsAscendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98MN/A
2022-05-12 09:00 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 19:27 ESTNewsAscendis Pharma Q1 2022 Earnings PreviewN/A
2022-05-09 22:24 ESTNewsAscendis Pharma: Biotech Bear Provides Attractive Entry PointN/A
2022-04-29 17:39 ESTNewsAscendis: Institutional Buying Activity Now Seen As Good Value By Market-MakersN/A
2022-03-25 08:03 ESTNewsAscendis Pharma prices $500.0M convertible senior notes offeringN/A
2022-03-23 22:32 ESTNewsAscendis Pharma slides on offering of $500M convertible senior notesN/A
2022-03-16 20:02 ESTNewsAscendis posts biggest intraday gain in six months as BofA upgrades on trial resultsN/A
2022-03-14 20:55 ESTNewsAscendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trialN/A
2022-03-03 04:55 ESTNewsAscendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13MN/A
2022-03-03 04:55 ESTNewsAscendis Pharma stock falls 7% despite Q4 bottom line beatN/A
2022-03-03 04:55 ESTNewsAscendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 18:03 ESTNewsAscendis Pharma FY Earnings PreviewN/A
2022-01-25 06:13 ESTNewsPfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunesN/A
2022-01-24 14:23 ESTNewsAscendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-24 14:23 ESTNewsPfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunesN/A
2022-01-14 01:12 ESTNewsAscendis Pharma's TransCon gets EU approval for growth hormone deficiency in childrenN/A
2021-12-30 05:41 ESTNewsAscendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-MakersN/A
2021-11-19 04:06 ESTNewsPhase 2 data shows durable response of Ascendis candidate for hypoparathyroidismN/A

About Ascendis Pharma A/S (ASND):

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

See Advanced Chart

General

  • Name Ascendis Pharma A/S
  • Symbol ASND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 482
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ascendispharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 917.83
  • Price/Book (Most Recent Quarter) 8.08
  • Enterprise Value Revenue 1052.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$8.67
  • Next Year EPS Estimate -$7.26
  • Next Quarter EPS Estimate -$2.01
  • Return on Assets -25%
  • Return on Equity -58%
  • Earnings Per Share -$5.09
  • Revenue Per Share $0
  • Gross Profit 6.95 million
  • Quarterly Earnings Growth -78.7%
View More

Highlights

  • Market Capitalization 7.87 billion
  • Analyst Target Price $194.63
  • Book Value Per Share $8.43
View More

Share Statistics

  • Shares Outstanding 53.75 million
  • Shares Float 43.76 million
  • % Held by Insiders 3%
  • % Held by Institutions 101.6%
  • Shares Short 2.48 million
  • Shares Short Prior Month 2.21 million
  • Short Ratio 11.66
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.79
  • 52 Week High $183.98
  • 52 Week Low $96.24
  • 50 Day Moving Average 152.16
  • 200 Day Moving Average 158.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ascendis Pharma A/S (ASND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ascendis Pharma A/S (ASND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$535000-$3.15-$1.87-68.17%
2020-09-302020-11-11$2.76 million-$2.72-$1.87-45.17%
2020-06-302020-08-27$1.44 million-$2.33-$1.61-44.68%
2020-03-312020-05-19$2.23 million-$1.44-$1.41-2.66%
2019-12-312019-12-31$2.51 million-$1.89-$1.62-16.67%
2019-09-302019-11-18$2.44 million-$0.59-$1.2954.34%
2019-06-302019-08-28$3.62 million-$1.38-$1.33-4.4%
2019-03-312019-05-30$6.07 million-$1.38-$1.14-20.89%
2018-12-312018-12-31$12.06 million-$0.86-$1.1424.56%
2018-09-302018-11-28$23153.51-$0.92-$1.1922.87%
2018-06-302018-08-29$20949.72-$0.64-$1.0035.45%
2018-03-312018-05-30$34444.58-$1.25-$0.88-41.8%
2017-12-312018-03-28$362000-$1.13-$0.99-14.12%
2017-09-302017-11-16$546000-$1.22-$0.86-42.4%
2017-06-302017-08-18$533000-$1.11-$0.88-26.09%
2017-03-312017-05-23$398000-$0.87-$0.76-15.03%
2016-12-312017-03-22$855000-$0.55-$0.7122.7%
2016-09-302016-11-30$1.36 million-$0.76-$0.64-19.56%
2016-06-302016-08-31$1.21 million-$0.59-$0.658.96%
2016-03-312016-04-14$1.43 million-$0.59-$0.30-95.13%
2015-09-302015-11-12$2.37 million-$0.29-$0.5648.21%
2015-06-302015-08-24$2.25 million-$0.63-$0.43-46.51%
2015-03-312015-05-18$2.24 million$0.07-$0.39117.95%
2014-12-312015-01-28$2.83 million-$0.65

Ascendis Pharma A/S (ASND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ascendis Pharma A/S (ASND) Chart:

Ascendis Pharma A/S (ASND) News:

Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ascendis Pharma A/S (ASND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-09-19750CALL0 00TRUE00
2025-09-19800CALL0 00TRUE00
2025-09-19850CALL0 00TRUE00
2025-09-19900CALL0 00TRUE00
2025-09-19950CALL0 00TRUE00
2025-09-191000CALL0 00TRUE00
2025-09-191050CALL0 00TRUE00
2025-09-191100CALL0 00TRUE00
2025-09-191150CALL0 00TRUE00
2025-09-191200CALL0 00TRUE00
2025-09-1912563.5CALL0 00TRUE00
2025-09-191300CALL0 00TRUE00
2025-09-191350CALL0 00TRUE00
2025-09-1914035.5CALL0 10TRUE00
2025-09-191450CALL0 00TRUE00
2025-09-1915028CALL0 182.88TRUE00
2025-09-1915524.55CALL0 10TRUE00
2025-09-1916036.2CALL0 10TRUE00
2025-09-1916522.6CALL0 155.82TRUE00
2025-09-1917035CALL0 10056.86TRUE00
2025-09-1917514.13CALL0 1052.86TRUE00
2025-09-191807.85CALL0 6851.85TRUE00
2025-09-1918518.5CALL0 34748.7TRUE00
2025-09-1919013.85CALL0 1247.12TRUE00
2025-09-191957.8CALL0 650.15TRUE00
2025-09-192007CALL0 22049.27FALSE00
2025-09-192101.85CALL1 2550.61FALSE-0.35-0.16
2025-09-192202.2CALL0 1378.82FALSE00
2025-09-192300.61CALL0 783.1FALSE00
2025-09-192400.5CALL0 150111.66FALSE00
2025-09-192500.8CALL0 1127.27FALSE00
2025-09-192600.35CALL0 1141.75FALSE00
2025-09-19750PUT0 0433.52FALSE00
2025-09-19800PUT0 0407.62FALSE00
2025-09-19850PUT0 0383.38FALSE00
2025-09-19900PUT0 0360.58FALSE00
2025-09-19950PUT0 0339.04FALSE00
2025-09-191000PUT0 0318.62FALSE00
2025-09-191050PUT0 0299.18FALSE00
2025-09-191100PUT0 0280.63FALSE00
2025-09-191150PUT0 0262.86FALSE00
2025-09-191200PUT0 0245.79FALSE00
2025-09-191251.85PUT0 1229.35FALSE00
2025-09-191302.4PUT0 2213.48FALSE00
2025-09-191351.08PUT0 1198.1FALSE00
2025-09-191401.13PUT0 0183.17FALSE00
2025-09-191454.9PUT0 1168.63FALSE00
2025-09-191503PUT0 1019154.44FALSE00
2025-09-191550.9PUT0 12140.53FALSE00
2025-09-191600.77PUT0 21127.75FALSE00
2025-09-191651.56PUT0 229115.02FALSE00
2025-09-191701.27PUT0 258102.28FALSE00
2025-09-191751.49PUT0 690.82FALSE00
2025-09-191801.8PUT0 156980.73FALSE00
2025-09-191851.75PUT1 3154.48FALSE1.750
2025-09-191901.88PUT0 1152.16FALSE00
2025-09-191955.56PUT0 1251.87FALSE00
2025-09-192006.34PUT0 11750.31TRUE00
2025-09-1921018.04PUT0 545.67TRUE00
2025-09-1922033.7PUT0 042.05TRUE00
2025-09-192300PUT0 048.76TRUE00
2025-09-192400PUT0 065.03TRUE00
2025-09-192500PUT0 070.91TRUE00
2025-09-192600PUT0 081.03TRUE00
2025-10-17750CALL0 00TRUE00
2025-10-17800CALL0 00TRUE00
2025-10-1785103.5CALL0 0117.72TRUE00
2025-10-17900CALL0 0103.47TRUE00
2025-10-17950CALL0 00TRUE00
2025-10-171000CALL0 073.46TRUE00
2025-10-171050CALL0 083.41TRUE00
2025-10-171100CALL0 075.5TRUE00
2025-10-171150CALL0 077.06TRUE00
2025-10-171200CALL0 066.09TRUE00
2025-10-171250CALL0 066.87TRUE00
2025-10-171300CALL0 065.51TRUE00
2025-10-171350CALL0 061.44TRUE00
2025-10-171400CALL0 062.68TRUE00
2025-10-171450CALL0 062.63TRUE00
2025-10-171500CALL0 058.25TRUE00
2025-10-1715542.6CALL0 058.67TRUE00
2025-10-171600CALL0 055.11TRUE00
2025-10-171650CALL0 054.07TRUE00
2025-10-1717021.5CALL0 651.22TRUE00
2025-10-1717532CALL0 249.51TRUE00
2025-10-1718022.35CALL0 547.85TRUE00
2025-10-1718523.55CALL0 247.44TRUE00
2025-10-1719015.8CALL0 1545.24TRUE00
2025-10-1719513.9CALL1 1149.26TRUE0.60.05
2025-10-1720010.5CALL7 52945.23FALSE-0.5-0.05
2025-10-172107.35CALL1 7248.07FALSE7.350
2025-10-172205.7CALL0 21842.06FALSE00
2025-10-172302.78CALL0 342.62FALSE00
2025-10-172401.5CALL0 457.15FALSE00
2025-10-172500.5CALL1 442.42FALSE0.020.04
2025-10-172601.1CALL0 467.08FALSE00
2025-10-17750PUT0 0204.93FALSE00
2025-10-17800PUT0 0192.72FALSE00
2025-10-17850PUT0 0181.29FALSE00
2025-10-17900PUT0 0170.54FALSE00
2025-10-17950PUT0 0160.39FALSE00
2025-10-171000PUT0 0150.76FALSE00
2025-10-171050PUT0 1141.6FALSE00
2025-10-171100PUT0 1132.85FALSE00
2025-10-171150PUT0 0125.19FALSE00
2025-10-171201.85PUT0 1117.78FALSE00
2025-10-171252.45PUT0 2110.59FALSE00
2025-10-171302.9PUT0 3103.6FALSE00
2025-10-171351.43PUT0 096.79FALSE00
2025-10-171400PUT0 090.64FALSE00
2025-10-171450.8PUT0 184.55FALSE00
2025-10-171500PUT0 078.96FALSE00
2025-10-171552.49PUT0 175.73FALSE00
2025-10-171600PUT0 071.66FALSE00
2025-10-171651.86PUT0 155.24FALSE00
2025-10-171702.56PUT0 30156.32FALSE00
2025-10-1717510.9PUT0 048.81FALSE00
2025-10-171803.5PUT0 20847.05FALSE00
2025-10-171854.2PUT0 747.5FALSE00
2025-10-171905.7PUT0 1045.13FALSE00
2025-10-171958.54PUT0 144.45FALSE00
2025-10-172009.9PUT0 344.36TRUE00
2025-10-1721016.53PUT0 143.74TRUE00
2025-10-172200PUT0 041.09TRUE00
2025-10-1723051PUT0 140.21TRUE00
2025-10-1724070PUT0 039.42TRUE00
2025-10-172500PUT0 042.42TRUE00
2025-10-172600PUT0 048.13TRUE00
2025-12-19600CALL0 077.67TRUE00
2025-12-19650CALL0 081.99TRUE00
2025-12-19700CALL0 085.44TRUE00
2025-12-19750CALL0 154.76TRUE00
2025-12-19800CALL0 065.53TRUE00
2025-12-19850CALL0 066.07TRUE00
2025-12-19900CALL0 064.97TRUE00
2025-12-19950CALL0 063.15TRUE00
2025-12-191000CALL0 060.96TRUE00
2025-12-1910589CALL0 158.54TRUE00
2025-12-191100CALL0 058.46TRUE00
2025-12-191150CALL0 057.41TRUE00
2025-12-191200CALL0 057.25TRUE00
2025-12-1912579.9CALL0 3856.81TRUE00
2025-12-191300CALL0 156.13TRUE00
2025-12-191350CALL0 155.24TRUE00
2025-12-191400CALL0 354.81TRUE00
2025-12-1914545.54CALL0 253.76TRUE00
2025-12-1915037.5CALL0 253.48TRUE00
2025-12-191550CALL0 051.95TRUE00
2025-12-191600CALL0 6651.82TRUE00
2025-12-1916543.79CALL0 151.62TRUE00
2025-12-1917042.2CALL0 27150.2TRUE00
2025-12-1917531.9CALL0 549.6TRUE00
2025-12-1918034.23CALL0 8648.8TRUE00
2025-12-1918531.1CALL0 2947.79TRUE00
2025-12-1919023.7CALL0 647.49TRUE00
2025-12-1919524.9CALL0 6246.81TRUE00
2025-12-1920019.01CALL0 21046.64FALSE00
2025-12-1921017.83CALL0 8644.96FALSE00
2025-12-192209.1CALL0 6444.6FALSE00
2025-12-192305CALL0 143.31FALSE00
2025-12-192406CALL0 541.94FALSE00
2025-12-192504.3CALL0 840.91FALSE00
2025-12-192603.2CALL0 1041.47FALSE00
2025-12-192702.15CALL0 842.46FALSE00
2025-12-192801.45CALL0 652.8FALSE00
2025-12-192900.95CALL0 454.58FALSE00
2025-12-19600PUT0 0150.08FALSE00
2025-12-19650PUT0 1140.77FALSE00
2025-12-19700PUT0 0132.22FALSE00
2025-12-19750PUT0 0124.31FALSE00
2025-12-19800PUT0 20116.94FALSE00
2025-12-19850PUT0 1110.05FALSE00
2025-12-19900PUT0 21103.56FALSE00
2025-12-19950PUT0 197.44FALSE00
2025-12-191000PUT0 192.14FALSE00
2025-12-191052.1PUT0 387.06FALSE00
2025-12-191102.65PUT0 482.63FALSE00
2025-12-191150.6PUT0 078.32FALSE00
2025-12-191200.85PUT0 274.5FALSE00
2025-12-191251.05PUT0 071.07FALSE00
2025-12-191300PUT0 170.74FALSE00
2025-12-191350PUT0 159.79FALSE00
2025-12-191409.23PUT0 7654.15FALSE00
2025-12-191450PUT0 153.62FALSE00
2025-12-191500PUT0 051.77FALSE00
2025-12-191550PUT0 052.16FALSE00
2025-12-191600PUT0 051.61FALSE00
2025-12-191650PUT0 050.53FALSE00
2025-12-191706.2PUT0 31549.5FALSE00
2025-12-191750PUT0 049.08FALSE00
2025-12-191800PUT0 048.55FALSE00
2025-12-1918527.5PUT0 16647.92FALSE00
2025-12-191900PUT0 046.8FALSE00
2025-12-1919518.9PUT0 1145.97FALSE00
2025-12-1920018.5PUT0 2046.23TRUE00
2025-12-192100PUT0 145.37TRUE00
2025-12-1922051.9PUT0 343.88TRUE00
2025-12-192300PUT0 042.56TRUE00
2025-12-192400PUT0 141.79TRUE00
2025-12-192500PUT0 041.01TRUE00
2025-12-1926077.4PUT0 039.69TRUE00
2025-12-192700PUT0 039.9TRUE00
2025-12-192800PUT0 041.28TRUE00
2025-12-192900PUT0 043.5TRUE00
2026-01-16750CALL0 068.63TRUE00
2026-01-16800CALL0 062.96TRUE00
2026-01-16850CALL0 060.92TRUE00
2026-01-16900CALL0 058.63TRUE00
2026-01-16950CALL0 056.2TRUE00
2026-01-161000CALL0 056.72TRUE00
2026-01-161050CALL0 056.05TRUE00
2026-01-161100CALL0 054.75TRUE00
2026-01-161150CALL0 053.07TRUE00
2026-01-161200CALL0 053.4TRUE00
2026-01-161250CALL0 052.85TRUE00
2026-01-161300CALL0 052.48TRUE00
2026-01-1613545.5CALL0 151.85TRUE00
2026-01-161400CALL0 051.53TRUE00
2026-01-161450CALL0 051.13TRUE00
2026-01-1615037.5CALL0 050.44TRUE00
2026-01-161550CALL0 049.87TRUE00
2026-01-1616035.98CALL0 649.2TRUE00
2026-01-1616524.85CALL0 2148.88TRUE00
2026-01-1617037CALL0 21148.39TRUE00
2026-01-1617525.7CALL0 647.87TRUE00
2026-01-1618035.2CALL0 447.57TRUE00
2026-01-1618529.65CALL0 1647.09TRUE00
2026-01-1619033.07CALL0 846.67TRUE00
2026-01-1619522.9CALL0 945.98TRUE00
2026-01-1620021.5CALL0 3745.99FALSE00
2026-01-1621016.4CALL0 444.34FALSE00
2026-01-1622014.1CALL0 143.26FALSE00
2026-01-1623012CALL2 42343.2FALSE120
2026-01-162407CALL0 146142.53FALSE00
2026-01-162504.83CALL0 341.53FALSE00
2026-01-162600CALL0 040.54FALSE00
2026-01-162700CALL0 040.46FALSE00
2026-01-162802.6CALL0 341.12FALSE00
2026-01-162901.25CALL0 349.56FALSE00
2026-01-163000CALL0 050.91FALSE00
2026-01-16750PUT0 0110.05FALSE00
2026-01-16800PUT0 0103.54FALSE00
2026-01-16850PUT0 097.45FALSE00
2026-01-16900PUT0 091.73FALSE00
2026-01-16950PUT0 086.79FALSE00
2026-01-161000PUT0 082.08FALSE00
2026-01-161050PUT0 077.57FALSE00
2026-01-161100.75PUT0 274.02FALSE00
2026-01-161150PUT0 070.52FALSE00
2026-01-161200PUT0 067.39FALSE00
2026-01-161250PUT0 064.86FALSE00
2026-01-161300PUT0 564.36FALSE00
2026-01-161355.23PUT0 2753.38FALSE00
2026-01-161403.78PUT0 1950.33FALSE00
2026-01-161450PUT0 1449.58FALSE00
2026-01-1615010.9PUT0 850.64FALSE00
2026-01-161557.1PUT0 150.1FALSE00
2026-01-161607.58PUT0 248.78FALSE00
2026-01-161656.8PUT0 2448.97FALSE00
2026-01-1617020.3PUT0 947.79FALSE00
2026-01-1617526.1PUT0 147.83FALSE00
2026-01-1618010.43PUT0 1346.92FALSE00
2026-01-1618512.07PUT0 2646.69FALSE00
2026-01-1619014.49PUT0 746.38FALSE00
2026-01-1619523.7PUT0 845.56FALSE00
2026-01-1620025.6PUT0 845.21TRUE00
2026-01-1621028.6PUT0 144.32TRUE00
2026-01-162200PUT0 042.93TRUE00
2026-01-162300PUT0 042.58TRUE00
2026-01-162400PUT0 041.4TRUE00
2026-01-162500PUT0 040.95TRUE00
2026-01-162600PUT0 040.13TRUE00
2026-01-162700PUT0 039.51TRUE00
2026-01-162800PUT0 040.63TRUE00
2026-01-162900PUT0 041.28TRUE00
2026-01-163000PUT0 044.19TRUE00
2026-04-171000CALL0 053.42TRUE00
2026-04-171050CALL0 051.89TRUE00
2026-04-171100CALL0 052.06TRUE00
2026-04-171150CALL0 051.31TRUE00
2026-04-171200CALL0 051.29TRUE00
2026-04-171250CALL0 051.01TRUE00
2026-04-171300CALL0 050.93TRUE00
2026-04-171350CALL0 050.44TRUE00
2026-04-171400CALL0 050.26TRUE00
2026-04-171450CALL0 049.88TRUE00
2026-04-171500CALL0 049.32TRUE00
2026-04-171550CALL0 049.6TRUE00
2026-04-171600CALL0 048.72TRUE00
2026-04-171650CALL0 048.48TRUE00
2026-04-171700CALL0 048.18TRUE00
2026-04-1717544.9CALL0 1347.9TRUE00
2026-04-171800CALL0 047.47TRUE00
2026-04-171850CALL0 047.17TRUE00
2026-04-171900CALL0 047.07TRUE00
2026-04-171950CALL0 046.14TRUE00
2026-04-1720030.93CALL0 245.68FALSE00
2026-04-1721027.9CALL0 144.95FALSE00
2026-04-172200CALL0 044.13FALSE00
2026-04-1723017.75CALL0 143.17FALSE00
2026-04-172400CALL0 042.34FALSE00
2026-04-172500CALL0 041.73FALSE00
2026-04-172600CALL0 041.24FALSE00
2026-04-172700CALL0 040.77FALSE00
2026-04-172800CALL0 040.31FALSE00
2026-04-172903.7CALL0 240.02FALSE00
2026-04-173000CALL0 039.88FALSE00
2026-04-171000PUT0 067.38FALSE00
2026-04-171050PUT0 065.1FALSE00
2026-04-171102.15PUT0 163.27FALSE00
2026-04-171152.7PUT0 152.64FALSE00
2026-04-171200PUT0 050.41FALSE00
2026-04-171250PUT0 050.05FALSE00
2026-04-171300PUT0 050.01FALSE00
2026-04-171350PUT0 049.71FALSE00
2026-04-171400PUT0 049.22FALSE00
2026-04-171450PUT0 049.07FALSE00
2026-04-171500PUT0 048.7FALSE00
2026-04-171550PUT0 048.53FALSE00
2026-04-171600PUT0 048.15FALSE00
2026-04-171650PUT0 047.93FALSE00
2026-04-171700PUT0 047.52FALSE00
2026-04-171750PUT0 047.44FALSE00
2026-04-171800PUT0 046.61FALSE00
2026-04-1718518.04PUT0 046.65FALSE00
2026-04-171900PUT0 046.25FALSE00
2026-04-171950PUT0 045.71FALSE00
2026-04-172000PUT0 045.35TRUE00
2026-04-172100PUT0 044.47TRUE00
2026-04-172200PUT0 043.68TRUE00
2026-04-172300PUT0 042.92TRUE00
2026-04-172400PUT0 042.25TRUE00
2026-04-172500PUT0 041.5TRUE00
2026-04-172600PUT0 040.67TRUE00
2026-04-172700PUT0 040.18TRUE00
2026-04-172800PUT0 039.47TRUE00
2026-04-172900PUT0 039.32TRUE00
2026-04-173000PUT0 039.83TRUE00
2026-06-18800CALL0 056.9TRUE00
2026-06-18850CALL0 054.84TRUE00
2026-06-18900CALL0 053.78TRUE00
2026-06-18950CALL0 053.29TRUE00
2026-06-181000CALL0 052.75TRUE00
2026-06-181050CALL0 052.14TRUE00
2026-06-181100CALL0 051.46TRUE00
2026-06-181150CALL0 050.73TRUE00
2026-06-181200CALL0 050.54TRUE00
2026-06-181250CALL0 050.18TRUE00
2026-06-181300CALL0 049.98TRUE00
2026-06-181350CALL0 049.62TRUE00
2026-06-181400CALL0 1049.25TRUE00
2026-06-181450CALL0 048.75TRUE00
2026-06-181500CALL0 048.59TRUE00
2026-06-1815551.5CALL0 248.27TRUE00
2026-06-1816049CALL0 247.93TRUE00
2026-06-1816536.9CALL0 247.74TRUE00
2026-06-1817037CALL0 1047.42TRUE00
2026-06-1817542.7CALL0 147.33TRUE00
2026-06-1818044CALL8 1548.42TRUE440
2026-06-1818531.8CALL0 146.78TRUE00
2026-06-1819035.5CALL0 1146.5TRUE00
2026-06-1819536.2CALL0 246.04TRUE00
2026-06-1820025.8CALL0 345.94FALSE00
2026-06-1821028.5CALL0 1645.31FALSE00
2026-06-1822024.51CALL0 444.41FALSE00
2026-06-1823018.6CALL0 443.26FALSE00
2026-06-182400CALL0 042.54FALSE00
2026-06-1825013.5CALL0 141.77FALSE00
2026-06-182600CALL0 040.97FALSE00
2026-06-182700CALL0 041.06FALSE00
2026-06-182800CALL0 040.31FALSE00
2026-06-182900CALL0 039.92FALSE00
2026-06-183000CALL0 039.7FALSE00
2026-06-18800PUT0 064.67FALSE00
2026-06-18850PUT0 071.83FALSE00
2026-06-18900PUT0 069.14FALSE00
2026-06-18950PUT0 066.75FALSE00
2026-06-181000PUT0 054.69FALSE00
2026-06-181050PUT0 053.61FALSE00
2026-06-181100PUT0 050.94FALSE00
2026-06-181150PUT0 050.67FALSE00
2026-06-181200PUT0 050.03FALSE00
2026-06-181254PUT0 449.75FALSE00
2026-06-181309.08PUT0 049.23FALSE00
2026-06-181350PUT0 049.03FALSE00
2026-06-181400PUT0 048.91FALSE00
2026-06-181450PUT0 048.74FALSE00
2026-06-1815016.25PUT0 248.4FALSE00
2026-06-1815522.5PUT0 147.93FALSE00
2026-06-1816016.2PUT0 247.83FALSE00
2026-06-1816525.21PUT0 247.58FALSE00
2026-06-1817025.05PUT0 247.1FALSE00
2026-06-1817526.3PUT0 4446.78FALSE00
2026-06-1818033.3PUT0 946.58FALSE00
2026-06-1818535.6PUT0 846.33FALSE00
2026-06-181900PUT0 046.05FALSE00
2026-06-1819530.4PUT0 145.5FALSE00
2026-06-1820044.5PUT0 245.23TRUE00
2026-06-1821038.5PUT0 144.67TRUE00
2026-06-182200PUT0 043.56TRUE00
2026-06-182300PUT0 042.56TRUE00
2026-06-182400PUT0 042.17TRUE00
2026-06-182500PUT0 041.3TRUE00
2026-06-1826090.48PUT0 26940.95TRUE00
2026-06-182700PUT0 040.2TRUE00
2026-06-182800PUT0 039.26TRUE00
2026-06-182900PUT0 039.33TRUE00
2026-06-183000PUT0 039TRUE00

Latest ASND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$79.93
Jun 13, 2022 7:59 PM EST4$79.91
Jun 13, 2022 7:59 PM EST118$79.93
Jun 13, 2022 7:59 PM EST9$79.97
Jun 13, 2022 7:59 PM EST17$79.97

Ascendis Pharma A/S (ASND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm
2019-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm
2019-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm
2020-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm
2019-02-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm
2019-03-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm
2019-03-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm
2019-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm
2019-04-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm
2019-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm
2020-10-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm
2020-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm
2019-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm
2020-07-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm